Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Weiner, LM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Adams, GP; Weiner, LM
      Radioimmunotherapy of solid tumors: From fairytale to reality

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    2. von Mehren, M; Arlen, P; Gulley, J; Rogatko, A; Cooper, HS; Meropol, NJ; Alpaugh, RK; Davey, M; McLaughlin, S; Beard, MT; Tsang, KY; Schlom, J; Weiner, LM
      The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma

      CLINICAL CANCER RESEARCH
    3. O'Dwyer, PJ; Manola, J; Valone, FH; Ryan, LM; Hines, JD; Wadler, S; Haller, DG; Arbuck, SG; Weiner, LM; Mayer, RJ; Benson, AB
      Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study

      JOURNAL OF CLINICAL ONCOLOGY
    4. Schilder, RJ; Gallo, JM; Millenson, MM; Bookman, MA; Weiner, LM; Rogatko, A; Rogers, B; Padavic-Shallers, K; Boente, M; Rosenblum, N; Adams, AL; Ciccotto, S; Ozols, RF
      Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, andtopotecan with peripheral-blood stem-cell support as front-line therapy

      JOURNAL OF CLINICAL ONCOLOGY
    5. Pandya, KJ; Yeap, BY; Weiner, LM; Krook, JE; Erban, JK; Schinella, RA; Davis, TE
      Megestrol and tamoxifen in patients with advanced endometrial cancer - An Eastern Cooperative Oncology Group study (E4882)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    6. McCall, AM; Shahied, L; Amoroso, AR; Horak, EM; Simmons, HH; Nielson, U; Adams, GP; Schier, R; Marks, JD; Weiner, LM
      Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity

      JOURNAL OF IMMUNOLOGY
    7. Powers, DB; Amersdorfer, P; Poul, MA; Nielsen, UB; Shalaby, MR; Adams, GP; Weiner, LM; Marks, JD
      Expression of single-chain Fv-Fc fusions in Pichia pastoris

      JOURNAL OF IMMUNOLOGICAL METHODS
    8. Segal, DM; Weiner, GJ; Weiner, LM
      Introduction: bispecific antibodies

      JOURNAL OF IMMUNOLOGICAL METHODS
    9. Adams, GP; Schier, R; McCall, AM; Simmons, HH; Horak, EM; Alpaugh, RK; Marks, JD; Weiner, LM
      High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules

      CANCER RESEARCH
    10. De Ferrari, GV; Canales, MA; Shin, I; Weiner, LM; Silman, I; Inestrosa, NC
      A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation

      BIOCHEMISTRY
    11. Weiner, LM
      Bispecific antibodies in cancer therapy

      CANCER JOURNAL
    12. Hudes, GR; Szarka, CE; Adams, A; Ranganathan, S; McCauley, RA; Weiner, LM; Langer, CJ; Litwin, S; Yeslow, G; Halberr, T; Qian, MX; Gallo, JM
      Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patientswith refractory solid malignancies

      CLINICAL CANCER RESEARCH
    13. von Mehren, M; Arlen, P; Tsang, KY; Rogatko, A; Meropol, N; Cooper, HS; Davey, M; McLaughlin, S; Schlom, J; Weiner, LM
      Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas

      CLINICAL CANCER RESEARCH
    14. Knox, SJ; Goris, ML; Tempero, M; Weiden, PL; Gentner, L; Breitz, H; Adams, GP; Axworthy, D; Gaffigan, S; Bryan, K; Fisher, DR; Colcher, D; Horak, ID; Weiner, LM
      Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer

      CLINICAL CANCER RESEARCH
    15. Adams, GP; Shaller, CC; Chappell, LL; Wu, C; Horak, EM; Simmons, HH; Litwin, S; Marks, JD; Weiner, LM; Brechbiel, MW
      Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

      NUCLEAR MEDICINE AND BIOLOGY
    16. Weiner, LM; Adams, GP
      New approaches to antibody therapy

      ONCOGENE
    17. Nielsen, UB; Adams, GP; Weiner, LM; Marks, JD
      Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cellsis independent of the intrinsic antibody affinity

      CANCER RESEARCH
    18. von Mehren, M; Weiner, LM
      Breast cancer: Biologic therapy

      STRATEGIES IN ADJUVANT THERAPY
    19. Segal, DM; Weiner, GJ; Weiner, LM
      Bispecific antibodies in cancer therapy

      CURRENT OPINION IN IMMUNOLOGY
    20. Amoroso, AR; Alpaugh, RK; Barth, MW; McCall, AM; Weiner, LM
      Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    21. McCall, AM; Adams, GP; Amoroso, AR; Nielsen, UB; Zhang, L; Horak, E; Simmons, H; Schier, R; Marks, JD; Weiner, LM
      Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis

      MOLECULAR IMMUNOLOGY
    22. Weiner, LM
      Monoclonal antibody therapy of cancer

      SEMINARS IN ONCOLOGY
    23. Weiner, LM
      An overview of monoclonal antibody therapy of cancer

      SEMINARS IN ONCOLOGY
    24. Weiner, LM
      Paclitaxel in the treatment of esophageal cancer

      SEMINARS IN ONCOLOGY
    25. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    26. ALPAUGH RK; SCHULTZ J; MCALEER C; GIANTONIO BJ; PERSSON R; BURNITE M; NIELSEN SE; VITEK L; PERSSON B; WEINER LM
      SUPERANTIGEN-TARGETED THERAPY - PHASE-I ESCALATING REPEAT DOSE TRIAL OF THE FUSION PROTEIN PNU-214565 IN PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES

      Clinical cancer research
    27. MOVSAS B; HANLON AL; LANCIANO R; SCHER RM; WEINER LM; SIGURDSON ER; HOFFMAN JP; EISENBERG BL; COOPER HS; PROVINS S; COIA LR
      PHASE-I DOSE ESCALATING TRIAL OF HYPERFRACTIONATED PREOPERATIVE CHEMORADIATION FOR LOCALLY ADVANCED RECTAL-CANCER

      International journal of radiation oncology, biology, physics
    28. ALPAUGH RK; WEINER LM; PERSSON R; PERSSON B
      OVERVIEW OF CLINICAL-TRIALS EMPLOYING ANTIBODY-TARGETED SUPERANTIGENS

      Advanced drug delivery reviews
    29. ADAMS GP; SCHIER R; MARSHALL K; WOLF EJ; MCCALL AM; MARKS JD; WEINER LM
      INCREASED AFFINITY LEADS TO IMPROVED SELECTIVE TUMOR DELIVERY OF SINGLE-CHAIN FV ANTIBODIES

      Cancer research
    30. KELLER SM; RYAN LM; COIA LR; DANG P; VAUGHT DJ; DIGGS C; WEINER LM; BENSON AB
      HIGH-DOSE CHEMORADIOTHERAPY FOLLOWED BY ESOPHAGECTOMY FOR ADENOCARCINOMA OF THE ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION - RESULTS OF A PHASE-II STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP

      Cancer
    31. ADAMS GP; SCHIER R; MCCALL AM; CRAWFORD RS; WOLF EJ; WEINER LM; MARKS JD
      PROLONGED IN-VIVO TUMOR RETENTION OF A HUMAN DIABODY TARGETING THE EXTRACELLULAR DOMAIN OF HUMAN HER2 NEU/

      British Journal of Cancer
    32. LATTANZI JP; COIA LR; SCHER RM; ENGSTROM PF; HOFFMAN JP; EISENBERG BF; SIGURSDSON ER; EPSTEIN BE; WEINER LM
      A PROSPECTIVE PHASE I II STUDY OF INTRAARTERIAL CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION-THERAPY FOR SURGICALLY UNRESECTABLE CARCINOMA CONFINED TO THE LIVER/

      GI cancer
    33. PERETZ M; WEINER LM; BURSTEIN Y
      CYSTEINE REACTIVITY IN THERMOANAEROBACTER-BROCKII ALCOHOL-DEHYDROGENASE

      Protein science
    34. NIELSEN SE; ZEUTHEN J; PERSSON B; SVEDBERG A; PERSSON R; WEINER LM; HANSEN HH
      A PHASE-I TRIAL OF ESCALATING REPEATED DOSES OF PNU-214565 IN PATIENTS WITH ADVANCED COLORECTAL AND OTHER GASTROINTESTINAL ADENOCARCINOMAS

      European journal of cancer
    35. GIANTONIO BJ; ALPAUGH RK; SCHULTZ J; MCALEER C; NEWTON DW; SHANNON B; GUEDEZ Y; KOTB M; VITEK L; PERSSON R; GUNNARSSON PO; KALLAND T; DOHLSTEN M; PERSSON B; WEINER LM
      SUPERANTIGEN-BASED IMMUNOTHERAPY - A PHASE-I TRIAL OF PNU-214565, A MONOCLONAL-ANTIBODY STAPHYLOCOCCAL-ENTEROTOXIN A RECOMBINANT FUSION PROTEIN, IN ADVANCED PANCREATIC AND COLORECTAL-CANCER

      Journal of clinical oncology
    36. MOVSAS B; HANLON AL; LANCIANO RM; SCHER RM; WEINER LM; SIGURDSON ER; HOFFMAN JP; COOPER HS; PROVINS S; COIA LR
      PHASE-I DOSE ESCALATING TRIAL OF HYPERFRACTINATED PREOPERATIVE CHEMORADIATION FOR LOCALLY ADVANCED RECTAL-CANCER

      International journal of radiation oncology, biology, physics
    37. WEINER LM; ALPAUGH RK; VONMEHREN M
      REDIRECTED CELLULAR CYTOTOXICITY EMPLOYING BISPECIFIC ANTIBODIES AND OTHER MULTIFUNCTIONAL BINDING-PROTEINS

      Cancer immunology and immunotherapy
    38. CLARK JI; ALPAUGH RK; VONMEHREN M; SCHULTZ J; GRALOW JR; CHEEVER MA; RING DB; WEINER LM
      INDUCTION OF MULTIPLE ANTI-C-ERB-2 SPECIFICITIES ACCOMPANIES A CLASSICAL IDIOTYPIC CASCADE FOLLOWING 2B1 BISPECIFIC MONOCLONAL-ANTIBODY TREATMENT

      Cancer immunology and immunotherapy
    39. WEINER LM; COLARUSSO P; GOLDBERG M; DRESLER C; COIA LR
      COMBINED-MODALITY THERAPY FOR ESOPHAGEAL CANCER - PHASE-I TRIAL OF ESCALATING DOSES OF PACLITAXEL IN COMBINATION WITH CISPLATIN, 5-FLUOROURACIL, AND HIGH-DOSE RADIATION BEFORE ESOPHAGECTOMY

      Seminars in oncology
    40. SHIN I; SILMAN I; WEINER LM
      INTERACTION OF PARTIALLY UNFOLDED FORMS OF TORPEDO ACETYLCHOLINESTERASE WITH LIPOSOMES

      Protein science
    41. WEINER LM; ALPAUGH RK; AMOROSO AR; ADAMS GP; RING DB; BARTH MW
      HUMAN NEUTROPHIL INTERACTIONS OF A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING TUMOR AND HUMAN FC-GAMMA-RIII

      Cancer immunology and immunotherapy
    42. GEORGE AJT; JAMAR F; TAI MS; HEELAN BT; ADAMS GP; MCCARTNEY JE; HOUSTON LL; WEINER LM; OPPERMANN H; PETERS AM; HUSTON JS
      RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE (VOL 92, PG 8358, 1995)

      Proceedings of the National Academy of Sciences of the United Statesof America
    43. SCHIER R; BYE J; APELL G; MCCALL A; ADAMS GP; MALMQVIST M; WEINER LM; MARKS JD
      ISOLATION OF HIGH-AFFINITY MONOMERIC HUMAN ANTI-C-ERBB-2 SINGLE-CHAINFV USING AFFINITY-DRIVEN SELECTION

      Journal of Molecular Biology
    44. PINKUS R; WEINER LM; DANIEL V
      ROLE OF OXIDANTS AND ANTIOXIDANTS IN THE INDUCTION OF AP-1, NF-KAPPA-B, AND GLUTATHIONE-S-TRANSFERASE GENE-EXPRESSION

      The Journal of biological chemistry
    45. AMOROSO AR; CLARK JI; LITWIN S; HSIEHMA S; SHI T; ALPAUGH RK; ADAMS GP; WOLF EJ; RING DB; WEINER LM
      BINDING CHARACTERISTICS AND ANTITUMOR PROPERTIES OF 1A10 BISPECIFIC ANTIBODY RECOGNIZING GP40 AND HUMAN TRANSFERRIN RECEPTOR

      Cancer research
    46. MUNN DH; BREE AG; BEALL AC; KAVIANI MD; SABIO H; SCHAUB RG; ALPAUGH RK; WEINER LM; GOLDMAN SJ
      RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN NONHUMAN-PRIMATES - SELECTIVE EXPANSION OF A CD16(-KILLER-CELLS() MONOCYTE SUBSETWITH PHENOTYPIC SIMILARITY TO PRIMATE NATURAL)

      Blood
    47. KRIGEL RL; PADAVICSHALLER K; TOOMEY C; COMIS RL; WEINER LM
      PHASE-I STUDY OF SEQUENTIALLY ADMINISTERED RECOMBINANT TUMOR-NECROSIS-FACTOR AND RECOMBINANT INTERLEUKIN-2

      Journal of immunotherapy with emphasis on tumor immunology
    48. LANGER CJ; CATALANO R; WEINER LM; SCHER R; BAGCHI P; SAREN B; COMIS RL
      PHASE-II EVALUATION OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (M-VAC) IN ADVANCED, MEASURABLE BREAST-CARCINOMA

      Cancer investigation
    49. DANIEL V; BERGELSON S; PINKUS R; WEINER LM
      REDOX REGULATION OF AP-1 INDUCTION AND GLUTATHIONE-S-TRANSFERASE GENE-EXPRESSION

      Journal of cellular biochemistry
    50. ALGAN O; COIA LR; KELLER SM; ENGSTROM PF; WEINER LM; SCHULTHEISS TE; HANKS GE
      MANAGEMENT OF ADENOCARCINOMA OF THE ESOPHAGUS WITH CHEMORADIATION ALONE OR CHEMORADIATION FOLLOWED BY ESOPHAGECTOMY - RESULTS OF SEQUENTIALNONRANDOMIZED PHASE-II STUDIES

      International journal of radiation oncology, biology, physics
    51. ADAMS GP; MCCARTNEY JE; WOLF EJ; EISENBERG J; TAI MS; HUSTON JS; STAFFORD WF; BOOKMAN MA; HOUSTON LL; WEINER LM
      OPTIMIZATION OF IN-VIVO TUMOR TARGETING IN SCID MICE WITH DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV - EFFECTS OF DOSE-ESCALATION AND REPEATED IV ADMINISTRATION

      Cancer immunology and immunotherapy
    52. MCCARTNEY JE; TAI MS; HUDZIAK RM; ADAMS GP; WEINER LM; JIN D; STAFFORD WF; LIU S; BOOKMAN MA; LAMINET AA; FAND I; HOUSTON LL; OPPERMANN H; HUSTON JS
      ENGINEERING DISULFIDE-LINKED SINGLE-CHAIN FV DIMERS [(SFV')(2)] WITH IMPROVED SOLUTION AND TARGETING PROPERTIES - ANTIDIGOXIN-26-10 (SFV')(2) AND ANTI-C-ERBB-2 741F8 (SFV')(2) MADE BY PROTEIN-FOLDING AND BONDED THROUGH C-TERMINAL CYSTEINYL PEPTIDES

      Protein engineering
    53. HAAS NB; SCHILDER RJ; NASH S; WEINER LM; CATALANO RC; OZOLS RF; ODWYER PJ
      A PHASE-II TRIAL OF WEEKLY INFUSIONAL 5-FLUOROURACIL IN COMBINATION WITH LOW-DOSE LEUCOVORIN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER

      Investigational new drugs
    54. ADAMS GP; MCCARTNEY JE; WOLF EJ; EISENBERG J; HUSTON JS; BOOKMAN MA; MOLDOFSKY P; STAFFORD WF; HOUSTON LL; WEINER LM
      ENHANCED TUMOR SPECIFICITY OF 741F8-1(SFV')(2), AN ANTI-C-ERBB-2 SINGLE-CHAIN FV DIMER, MEDIATED BY STABLE RADIOIODINE CONJUGATION

      The Journal of nuclear medicine
    55. CLARK JI; WEINER LM
      BIOLOGIC TREATMENT OF HUMAN CANCER

      Current problems in cancer
    56. WEINER LM
      KRIGEL,ROBERT,L. MD (1949-1994) - IN-MEMORIAM

      Seminars in oncology
    57. ADAMS GP; WEINER LM
      INTRACELLULAR SINGLE-CHAIN FV ANTIBODIES - A KNOCKOUT PUNCH FOR NEOPLASTIC-CELLS

      Gynecologic oncology
    58. GEORGE AJT; JAMAR F; TAI MS; HEELAN BT; ADAMS GP; MCCARTNEY JE; HOUSTON LL; WEINER LM; OPPERMANN H; PETERS AM; HUSTON JS
      RADIOMETAL LABELING OF RECOMBINANT PROTEINS BY A GENETICALLY-ENGINEERED MINIMAL CHELATION SITE - TC-99M COORDINATION BY SINGLE-CHAIN FV ANTIBODY FUSION PROTEINS THROUGH A C-TERMINAL CYSTEINYL PEPTIDE

      Proceedings of the National Academy of Sciences of the United Statesof America
    59. TAI MS; MCCARTNEY JE; ADAMS GP; JIN D; HUDZIAK RM; OPPERMANN H; LAMINET AA; BOOKMAN MA; WOLF EJ; LIU S; STAFFORD WF; FAND I; HOUSTON LL; WEINER LM; HUSTON JS
      TARGETING C-ERBB-2 EXPRESSING TUMORS USING SINGLE-CHAIN FV MONOMERS AND DIMERS

      Cancer research
    60. WEINER LM; CLARK JI; DAVEY M; LI WS; DEPALAZZO IG; RING DB; ALPAUGH RK
      PHASE-I TRIAL OF 2B1, A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING C-ERBB-2 AND FC-GAMMA-RIII

      Cancer research
    61. SALEH MN; GOLDMAN SJ; LOBUGLIO AF; BEALL AC; SABIO H; MCCORD MC; MINASIAN L; ALPAUGH RK; WEINER LM; MUNN DH
      CD16(- SPONTANEOUS ELEVATION AND PHARMACOLOGICAL INDUCTION BY RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR() MONOCYTES IN PATIENTS WITH CANCER )

      Blood
    62. PINKUS R; WEINER LM; DANIEL V
      ROLE OF QUINONE-MEDIATED GENERATION OF HYDROXYL RADICALS IN THE INDUCTION OF GLUTATHIONE-S-TRANSFERASE GENE-EXPRESSION

      Biochemistry
    63. REDEI I; GREEN F; HOFFMAN JP; WEINER LM; SCHER R; ODWYER PJ
      PHASE-II TRIAL OF PALA AND 6-METHYLMERCAPTOPURINE RIBOSIDE (MMPR) IN COMBINATION WITH 5-FLUOROURACIL IN ADVANCED PANCREATIC-CANCER

      Investigational new drugs
    64. SHPITZ B; CHAMBERS CA; SINGHAL AB; HOZUMI N; FERNANDES BJ; ROIFMAN CM; WEINER LM; RODER JC; GALLINGER S
      HIGH-LEVEL FUNCTIONAL ENGRAFTMENT OF SEVERE COMBINED IMMUNODEFICIENT MICE WITH HUMAN PERIPHERAL-BLOOD LYMPHOCYTES FOLLOWING PRETREATMENT WITH RADIATION AND ANTI-ASIALO G(M1)

      Journal of immunological methods
    65. WEINER LM; LI W; HOLMES M; CATALANO RB; DOVNARSKY M; PADAVIC K; ALPAUGH RK
      PHASE-I TRIAL OF RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR ANDRECOMBINANT GAMMA-INTERFERON - TOXICITY, MONOCYTOSIS, AND CLINICAL EFFECTS

      Cancer research
    66. WEINER LM; HOLMES M; RICHESON A; GODWIN A; ADAMS GP; HSIEHMA ST; RING DB; ALPAUGH RK
      BINDING AND CYTOTOXICITY CHARACTERISTICS OF THE BISPECIFIC MURINE MONOCLONAL ANTIBODY-2B1

      The Journal of immunology
    67. ALPAUGH K; LI W; HOLMES M; WEINER LM
      SUSTAINED MONOCYTOSIS WITH INDUCED DIFFERENTIATED PHENOTYPE IN A PHASE-I STUDY OF RECOMBINANT MACROPHAGE-COLONY STIMULATING FACTOR AND RECOMBINANT GAMMA-INTERFERON

      The Journal of immunology
    68. ADAMS GP; HUSTON JS; HOUSTON LL; FAND I; BOOKMAN MA; WEINER LM
      INVIVO TUMOR SPECIFICITY OF MONOMERIC AND DIMERIC FORMS OF THE 25 KD ANTI-C-ERBB-2 SINGLE-CHAIN FV (SFV) MOLECULE, 741F8

      The Journal of immunology
    69. ADAMS GP; MCCARTNEY JE; TAI MS; OPPERMANN H; HUSTON JS; STAFFORD WF; BOOKMAN MA; FAND I; HOUSTON LL; WEINER LM
      HIGHLY SPECIFIC IN-VIVO TUMOR TARGETING BY MONOVALENT AND DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV

      Cancer research
    70. DEPALAZZO IEG; ADAMS GP; SUNDARESHAN P; WONG AJ; TESTA JR; BIGNER DD; WEINER LM
      EXPRESSION OF MUTATED EPIDERMAL GROWTH-FACTOR RECEPTOR BY NONSMALL CELL LUNG CARCINOMAS

      Cancer research
    71. FEINSTEIN E; CANAANI E; WEINER LM
      DEPENDENCE OF NUCLEIC-ACID DEGRADATION ON IN-SITU FREE-RADICAL PRODUCTION BY ADRIAMYCIN

      Biochemistry
    72. YELINOVA VI; WEINER LM; SLEPNEVA IA; LEVINA AS
      REVERSIBLE MODIFICATION OF CYSTEINE RESIDUES OF NADPH-CYTOCHROME-P-450 REDUCTASE

      Biochemical and biophysical research communications
    73. WOLDMAN YY; WEINER LM; LYAKHOVICH VV
      DIFFERENT STRUCTURE OF THE COMPLEXES OF 2 CYTOCHROME-P-450 ISOZYMES WITH ACETANILIDE BY H-1-NMR RELAXATION AND SPECTROPHOTOMETRY

      Biochemical and biophysical research communications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:02:02